Authorized purpose: BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.
Clinical role
Frontal CXR triage and notification for suspected vertical ETT malposition
Images and patients
X-ray/Radiography · Chest/Lung
Key limitation
Keep in mind: The device assesses only vertical ETT-tip position relative to the carina, does not factor patient positioning, cannot detect esophageal intubation, provides no result when the carina is not well visualized, and may falsely alert on a properly positioned double-lumen ETT; the notification is informational and not diagnostic.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.
Which images or clinical context are in scope?Modality: X-ray/Radiography Anatomy or clinical context: Chest/Lung Input: Frontal chest X-ray in DICOM 3.0 from compatible X-ray scanners; the carina must be well visualized for a result.
Who uses it?Intended users: Appropriately trained medical specialists in hospital networks; the notification supports triage while full-image review and professional judgment remain required.
What does the software produce?Output: Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.
What is its most important limitation?Key limitation: The device assesses only vertical ETT-tip position relative to the carina, does not factor patient positioning, cannot detect esophageal intubation, provides no result when the carina is not well visualized, and may falsely alert on a properly positioned double-lumen ETT; the notification is informational and not diagnostic.
Clinical takeaway. Clinical role: BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.
Evidence takeaway. Evidence from the reviewed source record: A retrospective, blinded, multicenter pivotal study evaluated 921 cases from 5 US clinical sites against a 2-of-3 majority reference of senior board-certified radiologists. Sensitivity was 86.81% and specificity 92.02%; BriefCase time-to-notification was 4.93 minutes in 182 true-positive cases.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
BriefCase analyzes frontal chest X-rays in adults or transitional adolescents at least 18 years old to triage suspected vertically malpositioned endotracheal tubes relative to the carina; it flags tip positions more than 5 cm above, less than 2 cm above, or below the carina and requires standard-of-care image review.
Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.
Appropriately trained medical specialists in hospital networks; the notification supports triage while full-image review and professional judgment remain required.
The device assesses only vertical ETT-tip position relative to the carina, does not factor patient positioning, cannot detect esophageal intubation, provides no result when the carina is not well visualized, and may falsely alert on a properly positioned double-lumen ETT; the notification is informational and not diagnostic.
A retrospective, blinded, multicenter pivotal study evaluated 921 cases from 5 US clinical sites against a 2-of-3 majority reference of senior board-certified radiologists. Sensitivity was 86.81% and specificity 92.02%; BriefCase time-to-notification was 4.93 minutes in 182 true-positive cases.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
A retrospective, blinded, multicenter pivotal study evaluated 921 cases from 5 US clinical sites against a 2-of-3 majority reference of senior board-certified radiologists. Sensitivity was 86.81% and specificity 92.02%; BriefCase time-to-notification was 4.93 minutes in 182 true-positive cases.
BriefCase vertically malpositioned ETT pivotal validation
DesignRetrospective blinded multicenter validation against a 2-of-3 majority senior board-certified radiologist reference
Population921 frontal chest X-ray cases from 5 US clinical sites; time-to-notification analysis included 182 true-positive cases.
Scopeexact submission
Tested versionBriefCase vertically malpositioned ETT triage submitted in K221330; build not stated
Samplen=921
Sites5
IndependenceIndependence not established
K221330
The FDA states that pivotal cases were distinct in time or center from training cases. That establishes dataset separation, not independent investigators or sponsorship.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Frontal chest X-ray in DICOM 3.0 from compatible X-ray scanners; the carina must be well visualized for a result.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact system comprises Aidoc Hospital Server/Orchestrator for image acquisition, Aidoc Cloud Server for processing, and Aidoc Desktop Application for workflow integration. DICOM images are received, filtered, and de-identified before processing, with notifications sent to the desktop application and shared PACS workflows supported.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes BriefCase as three modules: an Aidoc Hospital Server (AHS/Orchestrator) for image acquisition, an Aidoc Cloud Server for image processing, and an Aidoc Desktop Application, with DICOM exams de-identified and uploaded to the cloud for analysis. Current hosting, data flow, and commercial configuration require vendor confirmation.
Scope: Exact FDA submission. Packet wording: "The device consists of the following three modules: (1) Aidoc Hospital Server (AHS/Orchestrator) for image acquisition; (2) Aidoc Cloud Server (ACS) for image processing; and (3) Aidoc Desktop Application for workflow integration." … "The BriefCase time-to-notification includes the time to get the DICOM exam, de-identify it, upload it to the cloud, analyze and send a notification on a positive suspect case back to the desktop application.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Source context, not route validation: Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: Desktop triage notification for suspected vertical ETT malposition with a compressed, unannotated grayscale preview labeled not for diagnostic use; the original image remains unchanged.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes BriefCase as three modules: an Aidoc Hospital Server (AHS/Orchestrator) for image acquisition, an Aidoc Cloud Server for image processing, and an Aidoc Desktop Application, with DICOM exams de-identified and uploaded to the cloud for analysis. Current hosting, data flow, and commercial configuration require vendor confirmation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The device consists of the following three modules: (1) Aidoc Hospital Server (AHS/Orchestrator) for image acquisition; (2) Aidoc Cloud Server (ACS) for image processing; and (3) Aidoc Desktop Application for workflow integration." … "The BriefCase time-to-notification includes the time to get the DICOM exam, de-identify it, upload it to the cloud, analyze and send a notification on a positive suspect case back to the desktop application.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.
The exact system comprises Aidoc Hospital Server/Orchestrator for image acquisition, Aidoc Cloud Server for processing, and Aidoc Desktop Application for workflow integration. DICOM images are received, filtered, and de-identified before processing, with notifications sent to the desktop application and shared PACS workflows supported.
Aidoc's current public Security & Privacy page says its security work is led by a CISO and security team, that it has adopted the NIST Cybersecurity Framework, and that its platform runs on AWS and Azure using EDR, encryption, SIEM and CSPM tooling. The page's list of standards and certifications did not load as readable text, so no certification is stated here.
Vendor-wide
Checked 2026-10-25
Vendor-wide marketing statement, not an independent attestation. It does not establish certificate scope or expiry, the controls of this exact release, data location, retention, identity and access, or incident-response terms for a deployed configuration. Obtain these from the vendor.
Aidoc's security page states that its platform runs on AWS and Azure and that customer data protection is achieved with the use of EDR, encryption, SIEM, CSPM and other technologies.
Vendor-wide
Checked 2026-10-27
Vendor statement, not an attestation. The page names Aidoc's platform generally and does not scope these capabilities to any specific product release; exact-release scope is not established. The page lists technology categories in use; it states no uptime, alerting or response-time SLAs.
The exact submission describes DICOM 3.0-compatible X-ray scanners, PACS and radiology workstations, Aidoc Hospital Server acquisition, Aidoc Cloud Server processing, and Aidoc Desktop workflow integration with filtered/de-identified image handling.
Aidoc's current official radiology page lists ETT malposition among radiology solutions and describes a Widget interface with key images/summary, workstation access, PACS worklist integration, and care-team communication; current family capabilities are not assumed to prove the exact K221330 build.
product family · checked 2026-09-07
Current family workflow context only; exact-version compatibility requires confirmation.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-07Last searched
26Fields reviewed
10Source classes checked
20Screened PubMed leads
6Screened trial leads
0Unreviewed FDA recall leads
The stored PubMed, ClinicalTrials.gov, and exact-submission recall metadata candidates were screened by identifier and count. The records were not treated as a full paper, trial, or postmarket review. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, vendor product page, literature index, trial registry, fda device recall, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not verified - checked 2026-09-07 - Exact FDA submission
No public amount, range, currency, geography, or contract term was established.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Aidoc BriefCase reimbursement NTAP CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. Aidoc's 2026-08-13 release announces a Medicare NTAP for CARE Body CT Multi-Triage; it does not name this product or clearance. This records what was found, not that none exists; eligibility depends on payer, site of service and use case.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-07 - Exact FDA submission
Training, credentialing, and implementation support terms were not established.
Authorized purpose: Passive study-level worklist triage for suspected pneumothorax and/or pleural effusion on adult PA or AP chest X-rays; it is not a proactive specialist alert.
Authorized purpose: Passive triage of adult AP chest radiographs for an endotracheal-tube tip more than 7 cm above the carina, less than 3 cm above the carina, below the carina in the right or left mainstem, or other listed malposition states.
Authorized purpose: Passive worklist prioritization for suspected pleural effusion and/or pneumothorax on frontal PA or AP chest radiographs in transitional adolescents aged 18-21 and adults aged 22 years and older; not diagnostic or a rule-out function.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.